Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Amoxicillin
Ceva Santé Animale
QJ01CA04
Amoxicillin
50 milligram(s)/gram
Premix for medicated feeding stuff
POM: Prescription Only Medicine as defined in relevant national legislation
Pigs
amoxicillin
Antibacterial
Authorised
2017-09-08
Health Products Regulatory Authority 07 March 2018 CRN000W20 Page 1 of 6 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrimoxin 50mg/g Premix for medicated feeding stuff for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Each g contains:_ ACTIVE SUBSTANCE: Amoxicillin (as trihydrate) 50 mg EXCIPIENTS: Wheat starch qsp 1 g For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Premix for medicated feeding stuff White-ivory homogeneous granules 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (weaned piglets) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In weaned piglets, in herds where infection has been confirmed; treatment of infections caused by _Streptococcus suis _susceptible to amoxicillin. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to penicillins, to other β-lactams or to the excipient. Do not use orally on rabbits, guinea pigs, hamsters and horses since the amoxicillin, like all the aminopenicillins, has adverse impact on caecal microflora population. Do not use in the presence of β-lactamase-producing bacteria. Health Products Regulatory Authority 07 March 2018 CRN000W20 Page 2 of 6 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Sick animals may have reduced feed intake and consequently, may require parenterally administered medication instead. The intake of medicated feed depends on the clinical condition of the animals. In order to obtain the correct dosage the concentration of amoxicillin has to be adjusted accordingly. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Official, national and regional antimicrobial policies should be taken into account when the product is used. Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Use of the product deviating from the instructions given in the SPC may increase Đọc toàn bộ tài liệu